ArticleJournal of cancer research and clinical oncology2013

Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model.

Carina Riediger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.